Download PDF
Semin intervent Radiol 2022; 39(04): 411-415
DOI: 10.1055/s-0042-1758076
Review Article

Oncopharmacology in Interventional Radiology

Junaid Raja
1   Division of Interventional Radiology, University of Alabama at Birmingham, Birmingham, Alabama
,
David C. Madoff
2   Division of Interventional Radiology, Yale New Haven Hospital, New Haven, Connecticut
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Abstract

The broad scope of malignancies treated in interventional oncology is mirrored by the breadth of oncotherapeutics, drugs used to treat cancer. Many of these treatments are administered endovascularly, though a group of therapies can be delivered percutaneously. Perhaps the best taxonomy of oncotherapeutics is based on their biological inactivity or activity and the mechanism by which they interact with treated and targeted tissues. As the fields of interventional oncology and oncotherapeutics continue to grow and expand, this framework may provide a more organized approach in helping distinguish and select the best therapy for patients.

Keywords

oncology - chemotherapy - endovascular - oncotherapeutics - interventional radiology - percutaneous - oncotherapeutics


Publication History

Article published online:
17 November 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Ramsey DE, Kernagis LY, Soulen MC, Geschwind JF. Chemoembolization of hepatocellular carcinoma. J Vasc Interv Radiol 2002; 13 (9, Pt 2): S211-S221
    CrossrefPubMedGoogle Scholar
  • 2 Van Ha TG. Transarterial chemoembolization for hepatocellular carcinoma. Semin Intervent Radiol 2009; 26: 270-275
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Marelli L, Stigliano R, Triantos C. et al. Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies. Cardiovasc Intervent Radiol 2007; 30 (01) 6-25
    CrossrefPubMedGoogle Scholar
  • 4 Case MD, Slovak R, Raja J, Kim HS. Interventional Oncology in Immuno-Oncology Part 2: Transcatheter therapies. Dig Dis Interv 2019; 03 (02) 155-162
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Sheth RA, Sabir S, Krishnamurthy S. et al. Endovascular embolization by transcatheter delivery of particles: past, present, and future. J Funct Biomater 2017; 8 (02) 12
    CrossrefPubMedGoogle Scholar
  • 6 Desai KR, Chen RI. Endovascular therapy for palliative care of cancer patients. Semin Intervent Radiol 2007; 24 (04) 382-390
    Article in Thieme ConnectPubMedGoogle Scholar
  • 7 Mukund A, Gamanagatti S. Ethanol ablation of renal cell carcinoma for palliation of symptoms in advanced disease. J Palliat Med 2010; 13 (02) 117-120
    CrossrefPubMedGoogle Scholar
  • 8 Gu Y-K, Luo RG, Huang JH, Si Tu QJ, Li XX, Gao F. Transarterial embolization ablation of hepatocellular carcinoma with a lipiodol-ethanol mixture. World J Gastroenterol 2010; 16 (45) 5766-5772
    CrossrefPubMedGoogle Scholar
  • 9 Erinjeri JP, Salhab HM, Covey AM, Getrajdman GI, Brown KT. Arterial patency after repeated hepatic artery bland particle embolization. J Vasc Interv Radiol 2010; 21 (04) 522-526
    CrossrefPubMedGoogle Scholar
  • 10 Mara M, Maskova J, Fucikova Z, Kuzel D, Belsan T, Sosna O. Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovasc Intervent Radiol 2008; 31 (01) 73-85
    CrossrefPubMedGoogle Scholar
  • 11 Idée J-M, Guiu B. Use of Lipiodol as a drug-delivery system for transcatheter arterial chemoembolization of hepatocellular carcinoma: a review. Crit Rev Oncol Hematol 2013; 88 (03) 530-549
    CrossrefPubMedGoogle Scholar
  • 12 Fiorentini G, Aliberti C, Tilli M. et al. Intra-arterial infusion of irinotecan-loaded drug-eluting beads (DEBIRI) versus intravenous therapy (FOLFIRI) for hepatic metastases from colorectal cancer: final results of a phase III study. Anticancer Res 2012; 32 (04) 1387-1395
    PubMedGoogle Scholar
  • 13 Lo C-M, Ngan H, Tso WK. et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002; 35 (05) 1164-1171
    CrossrefPubMedGoogle Scholar
  • 14 Ishikawa H, Kikkawa F, Tamakoshi K. et al. Distribution of platinum in human gynecologic tissues and lymph nodes after intravenous and intraarterial neoadjuvant chemotherapy. Anticancer Res 1996; 16 (6B): 3849-3853
    PubMedGoogle Scholar
  • 15 Garattini S. Pharmacokinetics in cancer chemotherapy. Eur J Cancer 2007; 43 (02) 271-282
    CrossrefPubMedGoogle Scholar
  • 16 Jarząbek M, Jargiełło T, Wolski A, Poluha P, Szczerbo-Trojanowska M. Drug-eluting microspheres transarterial chemoembolization (DEM TACE) in patients with liver metastases. Pilot study. Pol J Radiol 2011; 76 (03) 26-32
    PubMedGoogle Scholar
  • 17 Loewe C, Schindl M, Cejna M, Niederle B, Lammer J, Thurnher S. Permanent transarterial embolization of neuroendocrine metastases of the liver using cyanoacrylate and lipiodol: assessment of mid- and long-term results. AJR Am J Roentgenol 2003; 180 (05) 1379-1384
    CrossrefPubMedGoogle Scholar
  • 18 Habib A, Desai K, Hickey R, Thornburg B, Lewandowski R, Salem R. Transarterial approaches to primary and secondary hepatic malignancies. Nat Rev Clin Oncol 2015; 12 (08) 481-489
    CrossrefPubMedGoogle Scholar
  • 19 Wang MQ, Zhang JL, Duan F. et al. Prostate arterial chemoembolization for treatment of refractory hematuria and urinary retention in patients with localized advanced prostate cancer. Prostate Cancer Prostatic Dis 2022; DOI: 10.1038/s41391-022-00516-7.
    CrossrefPubMedGoogle Scholar
  • 20 Song J, Chen W, Zhu X. et al. Short-term efficacy, safety, and cost-effectiveness of transarterial chemoembolization with drug-eluting beads versus synchronous radiochemotherapy for cervical cancer. Int J Gynaecol Obstet 2019; 147 (01) 29-35
    CrossrefPubMedGoogle Scholar
  • 21 Zeng Y, Yin M, Zhao Y. et al. Combination of bronchial arterial infusion chemotherapy plus drug-eluting embolic transarterial chemoembolization for treatment of advanced lung cancer-a retrospective analysis of 23 patients. J Vasc Interv Radiol 2020; 31 (10) 1645-1653
    CrossrefPubMedGoogle Scholar
  • 22 Jiang C, Wang J, Wang Y. et al. Treatment outcome following transarterial chemoembolization in advanced bone and soft tissue sarcomas. Cardiovasc Intervent Radiol 2016; 39 (10) 1420-1428
    CrossrefPubMedGoogle Scholar
  • 23 Karalli A, Ghaffarpour R, Axelsson R. et al. Transarterial chemoembolization of renal cell carcinoma: a prospective controlled trial. J Vasc Interv Radiol 2017; 28 (12) 1664-1672
    CrossrefPubMedGoogle Scholar
  • 24 Requejo F, Marelli J, Ruiz Johnson A, Sampor C, Chantada G. The technique of superselective ophthalmic artery chemotherapy for retinoblastoma: the Garrahan Hospital experience. Interv Neuroradiol 2018; 24 (01) 93-99
    CrossrefPubMedGoogle Scholar
  • 25 Shaaban S, Negm A, Ibrahim EE, Elrazak AA. Chemotherapeutic agents for the treatment of hepatocellular carcinoma: efficacy and mode of action. Oncol Rev 2014; 8 (01) 246
    PubMedGoogle Scholar
  • 26 Alghorabi AA, Kabel AM, Elmaaboud M. Doxorubicin: insights into dynamics, clinical uses and adverse effects. J Cancer Res 2019; 7: 17-20
    PubMedGoogle Scholar
  • 27 Yamada R, Sato M, Kawabata M, Nakatsuka H, Nakamura K, Takashima S. Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 1983; 148 (02) 397-401
    CrossrefPubMedGoogle Scholar
  • 28 Mihlon F, Ray CE, Messersmith W. Chemotherapy agents: a primer for the interventional radiologist. Semin Intervent Radiol 2010; 27 (04) 384-390
    Article in Thieme ConnectPubMedGoogle Scholar
  • 29 Fiorentini G, Sarti D, Nani R, Aliberti C, Fiorentini C, Guadagni S. Updates of colorectal cancer liver metastases therapy: review on DEBIRI. Hepat Oncol 2020; 7 (01) HEP16
    CrossrefPubMedGoogle Scholar
  • 30 Toskich BB, Liu DM. Y90 radioembolization dosimetry: concepts for the interventional radiologist. Tech Vasc Interv Radiol 2019; 22 (02) 100-111
    CrossrefPubMedGoogle Scholar
  • 31 Kallini JR, Gabr A, Salem R, Lewandowski RJ. Transarterial radioembolization with yttrium-90 for the treatment of hepatocellular carcinoma. Adv Ther 2016; 33 (05) 699-714
    CrossrefPubMedGoogle Scholar
  • 32 Sato KT, Lewandowski RJ, Mulcahy MF. et al. Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres – safety, efficacy, and survival. Radiology 2008; 247 (02) 507-515
    CrossrefPubMedGoogle Scholar
  • 33 Mohamed M, Katz AW, Tejani MA. et al. Comparison of outcomes between SBRT, yttrium-90 radioembolization, transarterial chemoembolization, and radiofrequency ablation as bridge to transplant for hepatocellular carcinoma. Adv Radiat Oncol 2015; 1 (01) 35-42
    CrossrefPubMedGoogle Scholar
  • 34 Mouli SK, Raiter S, Harris K. et al. Yttrium-90 radioembolization to the prostate gland: proof of concept in a canine model and clinical translation. J Vasc Interv Radiol 2021; 32 (08) 1103-1112 .e12
    CrossrefPubMedGoogle Scholar
  • 35 Murali N, Mouli SK, Riaz A, Lewandowski RJ, Salem R. Extrahepatic applications of yttrium-90 radioembolization. Semin Intervent Radiol 2021; 38 (04) 479-481
    Article in Thieme ConnectPubMedGoogle Scholar
  • 36 Sacco R, Conte C, Tumino E. et al. Transarterial radioembolization for hepatocellular carcinoma: a review. J Hepatocell Carcinoma 2016; 3: 25-29
    CrossrefPubMedGoogle Scholar
  • 37 Navalkissoor S, Grossman A. Targeted alpha particle therapy for neuroendocrine tumours: the next generation of peptide receptor radionuclide therapy. Neuroendocrinology 2019; 108 (03) 256-264
    CrossrefPubMedGoogle Scholar
  • 38 Kim K, Kim S-J. Lu-177-based peptide receptor radionuclide therapy for advanced neuroendocrine tumors. Nucl Med Mol Imaging 2018; 52 (03) 208-215
    CrossrefPubMedGoogle Scholar
  • 39 Bouvry C, Palard X, Edeline J. et al. Transarterial radioembolization (TARE) agents beyond 90Y-microspheres. BioMed Res Int 2018; 2018: 1435302
    CrossrefPubMedGoogle Scholar
  • 40 Kanai T, Monden N, Sakon M. et al. A New Approach to the Treatment of Hepatocellular Carcinoma with Intrahepatic Metastases—Transarterial Immuno-Embolization (TIE) with OK-432 and Fibrinogen. In: Recent Advances in Management of Digestive Cancers. Springer; 1993: 669-671
    Google Scholar
  • 41 Valsecchi ME, Terai M, Eschelman DJ. et al. Double-blinded, randomized phase II study using embolization with or without granulocyte-macrophage colony-stimulating factor in uveal melanoma with hepatic metastases. J Vasc Interv Radiol 2015; 26 (04) 523-32 .e2
    CrossrefPubMedGoogle Scholar
  • 42 Sato T, Eschelman DJ, Gonsalves CF. et al. Immunoembolization of malignant liver tumors, including uveal melanoma, using granulocyte-macrophage colony-stimulating factor. J Clin Oncol 2008; 26 (33) 5436-5442
    CrossrefPubMedGoogle Scholar
  • 43 Shen L, Qi H, Chen S. et al. Cryoablation combined with transarterial infusion of pembrolizumab (CATAP) for liver metastases of melanoma: an ambispective, proof-of-concept cohort study. Cancer Immunol Immunother 2020; 69 (09) 1713-1724
    CrossrefPubMedGoogle Scholar
  • 44 Chargari C, Deutsch E, Blanchard P. et al. Brachytherapy: an overview for clinicians. CA Cancer J Clin 2019; 69 (05) 386-401
    CrossrefPubMedGoogle Scholar
  • 45 Gu YK, Fan WJ, Huang JH, Zhang L, Gao F. [Efficacy of CT-guided intra-tumoral dehydrated ethanol injection on lung metastasis from liver cancer]. Chin J Cancer 2007; 26 (10) 1112-1115
    PubMedGoogle Scholar
  • 46 Liang Y. et al. Transcatheter arterial chemoembolization combined with CT-guided percutaneous intratumor ethanol injection for liver metastases. Zhongguo Jieru Yingxiang Yu Zhiliaoxue 2007; 4 (01) 49-51
    PubMedGoogle Scholar
  • 47 Paz-Fumagalli R, Li X, Smallridge RC. Ethanol ablation of neck metastases from differentiated thyroid carcinoma. Semin Intervent Radiol 2019; 36 (05) 381-385
    Article in Thieme ConnectPubMedGoogle Scholar
  • 48 Yamashita TS, Rogers RT, Foster TR. et al. Ultrasound-guided percutaneous ethanol ablation for local regional recurrence of medullary thyroid cancer. Am Surg 2021; 87 (09) 1396-1399
    CrossrefPubMedGoogle Scholar
  • 49 Tselikas L, Champiat S, Sheth RA. et al. Interventional radiology for local immunotherapy in oncology. Clin Cancer Res 2021; 27 (10) 2698-2705
    CrossrefPubMedGoogle Scholar
  • 50 Raja J, Ludwig JM, Gettinger SN, Schalper KA, Kim HS. Oncolytic virus immunotherapy: future prospects for oncology. J Immunother Cancer 2018; 6 (01) 140
    CrossrefPubMedGoogle Scholar